Figure 2.

Change in Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) total symptom score and individual symptoms. (A) Median total symptom score (TSS) with 95% confidence interval (95% CI). (B) The median TSS with 95% CI in participants with remission after 2 years and participants without remission. (C) Individual symptom scores during treatment. Significance is defined as a statistically significant reduction compared with baseline at more than half of the time points. All analyses were done using generalized linear mixed models comparing baseline values with measurements during treatment. *P<0.05; **P<0.01; ***P<0.001